Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-21

Clinical Trial Update: A Bidirectional Observational Clinical Study of NAIC in the Treatment of Tumor Regression Patterns in LA-OSCC and LA-OPSCC

View source ↗

Summary

Observational bidirectional study of NAIC to examine tumor regression patterns in locally advanced oral squamous cell carcinoma and locally advanced oropharynge…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NAIC

Snippet

Sponsor: Zhujiang Hospital | Conditions: Oral Squamous Cell Carcinoma (OSCC), Oropharyngeal Squamous Cell Carcinoma (SCC) | Status: RECRUITING